• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[应用边际结构模型评估抗逆转录病毒疗法对5组HIV血清转化者的疗效]

[Marginal structural models application to estimate the effects of antiretroviral therapy in 5 cohorts of HIV seroconverters].

作者信息

Pérez-Hoyos Santiago, Ferreros Inmaculada, Hernán Miguel A

机构信息

Escuela Valenciana de Estudios en Salud, Valencia, España.

出版信息

Gac Sanit. 2007 Jan-Feb;21(1):76-83. doi: 10.1016/s0213-9111(07)71974-x.

DOI:10.1016/s0213-9111(07)71974-x
PMID:17306191
Abstract

OBJECTIVES

Standard methods to evaluate population effectiveness of treatments in observational studies have important limitations to appropriately adjust for time-dependent confounders. In this paper, we describe a recently developed methodological approach, marginal structural models (MSM), and use it to estimate the effectiveness of highly active antiretroviral therapy (HAART) on AIDS or death incidence.

SUBJECTS AND METHODS

We analyzed all subjects followed after 1997 as part of the GEMES project (comprised by several cohorts of HIV seroconverters in Spain) and who had not used HAART before the start of follow-up. To estimate the effect of HAART on AIDS or death incidence, we estimated the parameters of a marginal structural Cox model by fitting an inverse probability weighted logistic regression model. The estimation of the weights was based on CD4 count, time since seroconversion, sex, age, transmission category and previous treatment.

RESULTS

917 eligible subjects were followed for an average of 3.4 years and we observed 139 events. 42.1% of the participants received HAART during the study. The estimated rate ratio was 1.01 (95% confidence interval [CI], 0.68-1.49) using a Cox model without covariates and 0.90 (95% CI, 0.61-1.32) using a Cox model with time-dependent covariates. The causal rate ratio estimated for MSM was 0.74, (95% CI, 0.49-1.12).

CONCLUSIONS

The beneficial effect of HAART estimated by the MSM, but largely missed by conventional methods, is consistent with the findings of previous randomized studies. The MSM appropriately adjusted for the time-dependent covariate CD4 count, which is both a time-varying confounder and is affected by prior treatment.

摘要

目的

在观察性研究中,评估治疗对人群有效性的标准方法在适当调整随时间变化的混杂因素方面存在重要局限性。在本文中,我们描述了一种最近开发的方法学方法,即边际结构模型(MSM),并使用它来估计高效抗逆转录病毒疗法(HAART)对艾滋病或死亡发生率的有效性。

受试者与方法

我们分析了1997年之后随访的所有受试者,这些受试者是GEMES项目(由西班牙几个HIV血清转化者队列组成)的一部分,并且在随访开始前未使用过HAART。为了估计HAART对艾滋病或死亡发生率的影响,我们通过拟合逆概率加权逻辑回归模型来估计边际结构Cox模型的参数。权重的估计基于CD4细胞计数、血清转化后的时间、性别、年龄、传播类别和先前的治疗情况。

结果

917名符合条件的受试者平均随访了3.4年,我们观察到139例事件。42.1%的参与者在研究期间接受了HAART。使用无协变量的Cox模型估计的率比为1.01(95%置信区间[CI],0.68 - 1.49),使用具有随时间变化协变量的Cox模型估计的率比为0.90(95%CI,0.61 - 1.32)。MSM估计的因果率比为0.74(95%CI,0.49 - 1.12)。

结论

MSM估计的HAART的有益效果在很大程度上被传统方法忽略了,这与先前随机研究的结果一致。MSM对随时间变化的协变量CD4细胞计数进行了适当调整,CD4细胞计数既是一个随时间变化的混杂因素,又受先前治疗的影响。

相似文献

1
[Marginal structural models application to estimate the effects of antiretroviral therapy in 5 cohorts of HIV seroconverters].[应用边际结构模型评估抗逆转录病毒疗法对5组HIV血清转化者的疗效]
Gac Sanit. 2007 Jan-Feb;21(1):76-83. doi: 10.1016/s0213-9111(07)71974-x.
2
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.使用边际结构模型评估高效抗逆转录病毒疗法对获得性免疫缺陷综合征发生时间或死亡时间的影响。
Am J Epidemiol. 2003 Oct 1;158(7):687-94. doi: 10.1093/aje/kwg206.
3
Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category.高效抗逆转录病毒疗法在西班牙HIV血清转化者队列中的有效性:按传播类别划分的差异
AIDS. 2003 Feb 14;17(3):353-9. doi: 10.1097/00002030-200302140-00009.
4
Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.高效抗逆转录病毒疗法对感染HIV的儿童和青少年生存的长期有效性:一项10年随访研究
Clin Infect Dis. 2008 Feb 15;46(4):507-15. doi: 10.1086/526524.
5
Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.高效抗逆转录病毒治疗时代HIV血清阳性与血清阴性人群的死亡率:对何时开始治疗的启示
J Infect Dis. 2004 Sep 15;190(6):1046-54. doi: 10.1086/422848. Epub 2004 Aug 17.
6
Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters.1型人类免疫缺陷病毒血清转化者开始高效抗逆转录病毒治疗的时机与临床结局
Arch Intern Med. 2011 Sep 26;171(17):1560-9. doi: 10.1001/archinternmed.2011.401.
7
Determinants of survival following HIV-1 seroconversion after the introduction of HAART.高效抗逆转录病毒治疗(HAART)引入后HIV-1血清转化后的生存决定因素。
Lancet. 2003 Oct 18;362(9392):1267-74. doi: 10.1016/s0140-6736(03)14570-9.
8
Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.使用基于生物标志物的疾病进展等效性评估高效抗逆转录病毒疗法对人类免疫缺陷病毒感染者的有效性。
Am J Epidemiol. 2002 Apr 15;155(8):760-70. doi: 10.1093/aje/155.8.760.
9
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) /l.无症状HIV感染且CD4细胞计数>350×10⁶ /l的患者早期开始高效抗逆转录病毒治疗(HAART)的临床疗效。
AIDS. 2002 Jul 5;16(10):1371-81. doi: 10.1097/00002030-200207050-00009.
10
Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.用于估计齐多夫定对HIV阳性男性生存因果效应的边际结构模型。
Epidemiology. 2000 Sep;11(5):561-70. doi: 10.1097/00001648-200009000-00012.